article thumbnail

AIMS v. Garland: A Disappointment for Psilocybin Advocates, but Progressive Policy May Still be on the Horizon

Cannabis Law Report

Despite Petitioners’ noble cause, the case turned on a technicality after the Court determined that the DEA’s letter stating that such psilocybin treatment was not allowed, the document that prompted the lawsuit, was not a “final” decision of the Attorney General that the Court had jurisdiction to review. Background. Psilocybin. The RTT Act.

DEA 52
article thumbnail

Why we haven’t cured cancer

Otherside Farms

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. abst – 2003). 2003] – PubMed result. Inhibition of tumor angiogenesis by cannabinoids (full – 2003). abst – 2003). 10.1096/fj.02-0795fje

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bangkok Post Report: Cannabis clinics set to mushroom – currently 500 in operation

Cannabis Law Report

Department records show that the health condition of 74% of patients improves after such treatment. “Our plan is to open more cannabis clinics to cover most of the tambons across the nation,” Dr Kwanchai said. Can you elaborate on the cannabis oil treatment available at these clinics?

Oil 52
article thumbnail

Marijuana and HIV: Much More Than Palliative Aid

Greencamp

Drugs used for the treatment of HIV and AIDS are called antiretroviral medications, and there are several different classes of these drugs: Fusion/Entry Inhibitors (they prevent, or more precisely slow down HIV from entering healthy cells). 2003 ( 4 ). Mitchell; Short-Term Medical Cannabis Doesn’t Harm HIV+ Patients; 2003.

Marijuana 110
article thumbnail

Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment

Cannabis Info

Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment. In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression.

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

there has never been a better time for new treatment options. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/rosalind-watts-89527660/.